| abstract |
ABSTRACT A method of inhibiting endometriosis comprising administering to a human in need of treatment an effective amount of a compound having the formula (I) Wherein R1 and R3 are independently hydrogen, -CH3, , or , wherein Ar is optionally substituted phenyl; R2 is selected from the group consisting of pyrrolidine and piperidino; or a pharmaceutically acceptable salt of solvate thereof. |